Pluristem Therapeutics Inc (PSTI)

[bluehorsesho]

$30 million for the study, Dilution.......

this may be the reason for the shelf registration..........

let's hope BARDA funds the study, if not, we dilute......imhop

from article:

According to management, BARDA could come to a decision by the end of 2017 and, if approved, would fully fund the estimated $30M cost of the pivotal study. Currently, we expect this pivotal study to complete by mid-2018 and the US government may begin stockpiling of PLX-R18 as early as 3Q18.”